21Indexed trials
mesh condition
Neurocognitive Disorders
Intelligence
Neurocognitive Disorders intelligence: 21 indexed trials, 7 recruiting studies, 20 sponsors across 33 countries.
7Recruiting
20Sponsors
33Countries
Leading sponsors
University of Michigan21 recruiting
Eli Lilly and Company11 recruiting
Elizabeth K Rhodus10 recruiting
Genentech, Inc.10 recruiting
Hoffmann-La Roche10 recruiting
Hospices Civils de Lyon10 recruiting
MapLight Therapeutics11 recruiting
National Center of Neurology and Psychiatry, Japan10 recruiting
National Institutes of Health Clinical Center (CC)10 recruiting
Ospedale Policlinico San Martino11 recruiting
Eastern Virginia Medical School11 recruiting
QuantalX Neuroscience10 recruiting
Geographic activity
United States12trials
France5trials
Italy4trials
South Korea3trials
Portugal3trials
Poland3trials
Canada3trials
Hong Kong2trials
Spain2trials
Germany2trials
Australia2trials
Japan2trials
Leading interventions
BPN147701trials
Blood tests1trials
Caffeine citrate1trials
Crenezumab1trials
Dextrose Water1trials
Digital intervention1trials
Donanemab1trials
Drug: [18F]florbetaben1trials
EEG with event-related potential (ERP)1trials
Exercise1trials
FAM-HELP1trials
Amyloid PET CT1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.